跳至主要内容
临床试验/NL-OMON52393
NL-OMON52393招募中不适用

Predicting venous thromboembolism in patients with pancreatic cancer. - Predicting thrombosis in pancreatic cancer

Academisch Medisch Centrum0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Pancreatic cancer confirmed by histology or radiologic imaging.
  • * Planned for a new line of chemotherapy
  • * 18 years of age or older
  • * Fully capable of making health related decisions and written informed

排除标准

  • * Adjuvant chemotherapy.
  • * Current prophylactic or therapeutic anticoagulant therapy (unfractionated
  • heparin, low molecular weight heparin, vitamin K antagonists, or direct oral
  • anticoagulants).
  • * Venous thromboembolism < 3 months prior to chemotherapy.
  • * Surgery or chemotherapy within the last month
  • * The presence of an inferior vena cava filter
  • * Currently pregnant
  • * Life expectancy of <3 months
  • * Bacterial or viral infection in the previous 2 weeks, defined by fever and
  • clinical symptoms.

研究者

相似试验